Nanovery Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 15

Nanovery General Information

Description

Developer of an artificial intelligence nanorobot designed for quick and ultra-sensitive detection of challenging biomarkers. The company's platform captures circulating tumor DNA and emits a fluorescent signal, allowing point-of-care detection and predicting the deoxyribonucleic acid evolution of the cancer cells, enabling healthcare professionals to detect cancer and increase the patient's chance of survival significantly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Biosphere, Draymans Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Corporate Office
  • The Biosphere, Draymans Way
  • Newcastle Helix
  • Newcastle Upon Tyne NE4 5BX
  • England, United Kingdom
+44 0191

Nanovery Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 10-Jun-2025 Completed Generating Revenue
8. Later Stage VC 10-Apr-2025 Completed Generating Revenue
7. Later Stage VC 05-Apr-2023 Completed Generating Revenue
6. Grant 05-Apr-2023 Completed Generating Revenue
5. Early Stage VC 11-Nov-2022 Completed Generating Revenue
4. Early Stage VC 05-May-2021 Completed Generating Revenue
3. Grant 01-Apr-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2021 $105K Completed Generating Revenue
1. Accelerator/Incubator 07-Apr-2019 $105K $105K Completed Generating Revenue
To view Nanovery’s complete valuation and funding history, request access »

Nanovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
A Ordinary
Ordinary
A Ordinary 686,778 $0.000129 $2.25 $2.25 1x $2.25 29.02%
Ordinary 221,260 $0.000129 $2.25 $2.25 1x $2.25 9.35%
To view Nanovery’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanovery Patents

Nanovery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202402960-D0 Catalytic nucleic acid system Pending 29-Feb-2024
WO-2025181497-A1 Catalytic nucleic acid system Pending 29-Feb-2024
EP-3947725-A1 Apparatus, system and method Active 26-Mar-2019
EP-3947725-B1 Apparatus, system and method Active 26-Mar-2019
EP-3947725-C0 Apparatus, system and method Active 26-Mar-2019 C12Q1/6823
To view Nanovery’s complete patent history, request access »

Nanovery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanovery Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTools Innovator Accelerator/Incubator
Proven Connect Impact Investing Minority
Smartlink Holdings Holding Company Minority
Smartlink Partners Venture Capital Minority
JRH ASI Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Nanovery FAQs

  • When was Nanovery founded?

    Nanovery was founded in 2018.

  • Where is Nanovery headquartered?

    Nanovery is headquartered in Newcastle Upon Tyne, United Kingdom.

  • What is the size of Nanovery?

    Nanovery has 18 total employees.

  • What industry is Nanovery in?

    Nanovery’s primary industry is Other Healthcare Technology Systems.

  • Is Nanovery a private or public company?

    Nanovery is a Private company.

  • What is Nanovery’s current revenue?

    The current revenue for Nanovery is .

  • How much funding has Nanovery raised over time?

    Nanovery has raised $6.27M.

  • Who are Nanovery’s investors?

    BioTools Innovator, Proven Connect, Smartlink Holdings, Smartlink Partners, and JRH ASI are 5 of 15 investors who have invested in Nanovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process